Antibody testing to predict SARS-CoV-2 risk in immunocompromised people
Lancet
.
2025 Jan 25;405(10475):276-278.
doi: 10.1016/S0140-6736(25)00098-4.
Author
Christopher J A Duncan
1
Affiliation
1
Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne NE1 7RU, UK. Electronic address: christopher.duncan@ncl.ac.uk.
PMID:
39863352
DOI:
10.1016/S0140-6736(25)00098-4
No abstract available
Publication types
Comment